DongKook Pharmaceutical Co., Ltd. (KOSDAQ:086450)
South Korea · Delayed Price · Currency is KRW 22,300
+1,750 (8.52%)
Mar 27, 2026, 3:30 PM KST
DongKook Pharmaceutical Revenue
In the year 2025, DongKook Pharmaceutical had annual revenue of 926.88B KRW with 14.12% growth. DongKook Pharmaceutical had revenue of 242.88B in the quarter ending December 31, 2025, with 15.15% growth.
Revenue
926.88B
Revenue Growth
+14.12%
P/S Ratio
1.00
Revenue / Employee
751.73M
Employees
1,233
Market Cap
927.03B
Revenue Chart
Revenue History
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Dec 31, 2025 | 926.88B | 114.72B | 14.12% |
| Dec 31, 2024 | 812.17B | 81.17B | 11.10% |
| Dec 31, 2023 | 730.99B | 69.35B | 10.48% |
| Dec 31, 2022 | 661.65B | 67.45B | 11.35% |
| Dec 31, 2021 | 594.19B | 35.09B | 6.28% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2017 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2016 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| Daewoong | 2.07T |
| GC Biopharma | 1.99T |
| Chong Kun Dang Pharmaceutical | 1.69T |
| Dong-A Socio Holdings | 1.40T |
| Boryung | 1.02T |
| Huons Global | 825.44B |
| JW Pharmaceutical | 775.30B |
| Ildong Pharmaceutical | 566.93B |